Saliva Collection and Diagnostics - Global Strategic Business Report

The global market for Saliva Collection and Diagnostics was estimated at US$794.5 Million in 2024 and is projected to reach US$983.6 Million by 2030, growing at a CAGR of 3.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Saliva Collection and Diagnostics market.

Global Saliva Collection and Diagnostics Market - Key Trends & Drivers Summarized

Why Is Saliva-Based Diagnostics Gaining Popularity In The Healthcare Industry?

Saliva collection and diagnostics are transforming non-invasive medical testing, offering a convenient alternative to traditional blood tests. Saliva-based diagnostics are increasingly being used for disease detection, genetic testing, hormone analysis, and drug monitoring. The growing demand for home-based and point-of-care testing, particularly following the COVID-19 pandemic, has accelerated the adoption of saliva testing kits. These tests eliminate the need for needles, reducing patient discomfort and making diagnostics more accessible for children, elderly individuals, and those with needle phobia. With advancements in biotechnology, saliva-based diagnostics are now being used for early disease detection, including cancer, infectious diseases, and neurological disorders. As the demand for rapid and non-invasive diagnostics increases, the saliva collection and diagnostics market is experiencing significant growth.

What Technological Innovations Are Enhancing Saliva-Based Diagnostics?

Breakthroughs in molecular biology and biosensor technology are improving the accuracy and efficiency of saliva diagnostics. PCR-based (polymerase chain reaction) saliva tests are enabling highly sensitive detection of viral and bacterial infections. AI-powered data analysis and lab-on-a-chip technology are streamlining saliva-based genetic testing, allowing for faster and more precise results. Wearable biosensors that continuously monitor biomarkers in saliva are also emerging, providing real-time health tracking without invasive procedures. Additionally, improvements in saliva collection devices, such as stabilization buffers that preserve DNA and RNA integrity, are expanding the range of conditions that can be diagnosed using saliva samples. These innovations are making saliva-based testing a powerful tool for preventive and personalized medicine.

Which Healthcare Sectors Are Driving The Demand For Saliva Collection And Diagnostics?

The growing need for non-invasive diagnostics is driving adoption across multiple healthcare sectors, including infectious disease testing, genetic screening, endocrinology, and forensic science. The pharmaceutical industry is using saliva testing for drug development and clinical trials, while sports medicine professionals rely on saliva-based hormone monitoring to assess athlete performance and recovery. The rise of telemedicine and home healthcare services is further fueling demand for at-home saliva collection kits, enabling patients to submit samples without visiting a clinic. Additionally, the forensic and law enforcement sectors are increasingly using saliva-based DNA testing for criminal investigations and identity verification. With applications expanding across various fields, saliva diagnostics is becoming a mainstream healthcare solution.

What Factors Are Fueling The Growth Of The Saliva Collection And Diagnostics Market?

The growth in the saliva collection and diagnostics market is driven by rising demand for non-invasive testing, advancements in molecular diagnostics, and the expansion of telehealth services. The COVID-19 pandemic accelerated investment in saliva-based diagnostics for rapid viral detection, highlighting their potential for broader disease screening. The increasing prevalence of chronic diseases, including cancer and diabetes, is also driving research into saliva-based biomarker detection. The push for personalized medicine is leading to greater adoption of genetic and epigenetic testing using saliva samples. Additionally, government initiatives promoting early disease detection and affordable diagnostics are supporting market expansion. As technology continues to improve, saliva-based testing is expected to play a pivotal role in the future of healthcare.

Report Scope

The report analyzes the Saliva Collection and Diagnostics market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Collection Site (Parotid Gland Collection, Submandibular/Sublingual Gland Collection, Others); Application (Disease Diagnostics, Forensic Applications, Research); End-Use (Dentistry, Diagnostic Laboratories, Pharma & Biotech Companies, Research Institutes)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Parotid Gland Collection segment, which is expected to reach US$555.4 Million by 2030 with a CAGR of a 3.4%. The Submandibular / Sublingual Gland Collection segment is also set to grow at 4.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $216.4 Million in 2024, and China, forecasted to grow at an impressive 6.7% CAGR to reach $196.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Saliva Collection and Diagnostics Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Saliva Collection and Diagnostics Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Saliva Collection and Diagnostics Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott, Abionic SA, Arcis Biotechnology Ltd., AutoGen, Inc., DNA Genotek (an OraSure company) and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 43 Featured):

• Abbott
• Abionic SA
• Arcis Biotechnology Ltd.
• AutoGen, Inc.
• DNA Genotek (an OraSure company)
• Eli Health
• Hardy Diagnostics
• Neogen Corporation
• Oasis Diagnostics
• OraSure Technologies
• Phadebas
• Porex
• Salignostics
• Salimetrics, LLC
• Sarstedt AG & Co. KG
• Spectrum Solutions
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• ZRT Laboratory
• Zymo Research

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry